“Corporate venture arm investing in biotechnology and pharmaceutical companies that align with AbbVie's therapeutic areas.”
Alphabet's research and development biotech company focused on aging and longevity research.
A therapeutics company focused on pharmaceutical or medical technology development with limited public information available.
Biopharmaceutical company developing engineered protein therapeutics for cancer using expanded genetic code technology.
AbbVie has built a portfolio of 3 companies across 1 sector, including Biotech.
AbbVie has invested in 3+ companies across 1 different sectors.
AbbVie's portfolio spans Biotech. This diversification reflects the firm's broad investment thesis and sector expertise.
VentureKit
Turn your thesis into a complete fund launch package — strategy memo, LP pitch deck, financial models, and 11 more custom documents. Generated in 24 hours.
Build Your Fund Package